Heating Lyophilised Factor VIII Does Not Alter Its Recognition by Specific Antibodies
- 1 July 1997
- journal article
- research article
- Published by Wiley in Vox Sanguinis
- Vol. 73 (1) , 16-23
- https://doi.org/10.1046/j.1423-0410.1997.7310016.x
Abstract
Background and objectives: Alterations of factor VIII (FVIII) during preparation procedures can potentially affect its immunogenicity. One method evaluating such alterations could be by determining the reactivity of FVIII with specific antibodies. Materials and methods: Since heat treatment is currently used to reduce the risk of viral transmission, we evaluated the immunoreactivity of plasma‐derived FVIII before and after heating at different temperatures and for different periods. Freeze‐dried FVIII was used for these experiments as part of the validation procedure of a novel FVIII preparation. Results: Heating FVIII for up to 72 h at 80 °C does not alter its reactivity with specific rabbit antibodies or mouse monoclonal antibodies, although some loss of FVIII activity occurred after 72 h. After heating for 2 h at 100 °C, a procedure that reduced FVIII activity by about 50%, there were still no significant effects on FVIII reactivity with monoclonal antibodies. Conclusions: Freeze‐dried preparations of plasma‐derived FVIII seem to be resistant to heat‐induced structural denaturation.Keywords
This publication has 21 references indexed in Scilit:
- Factor VIII Inhibitors in Previously Treated Haemophilia A Patients with a Double Virus-inactivated Plasma Derived Factor VIII ConcentrateThrombosis and Haemostasis, 1997
- Variations in Antigenicity of Factor VIII Concentrates: Preclinical EvaluationVox Sanguinis, 1996
- No Detectable Alterations in Immunogenicity following Terminal Severe Dry-Heat Treatment of High-Purity Factor VIII (Liberate) and Factor IX (HP9) ConcentratesVox Sanguinis, 1995
- Healthy subjects produce both anti-factor VIII and specific anti-idiotypic antibodies.Journal of Clinical Investigation, 1994
- Inversions disrupting the factor VIII gene are a common cause of severe haemophilia ANature Genetics, 1993
- Factor VIII gene explains all cases of haemophilia AThe Lancet, 1992
- Inhibition of human coagulation factor VIII by monoclonal antibodies. Mapping of functional epitopes with the use of recombinant factor VIII fragmentsBiochemical Journal, 1989
- Differentiation of thrombin- and factor Xa-related amidolytic activity in plasma by means of a synthetic thrombin inhibitorThrombosis Research, 1984
- Induction of tolerance to factor VIII in a child with a high-titer inhibitor: In vitro and in vivo observationsThe Journal of Pediatrics, 1984
- Monoclonal anti-IgG autoantibodies derived from lipopolysaccharide-activated spleen cells of 129/Sv miceThe Journal of Experimental Medicine, 1982